Phlebitis Saltans, Symptom or Disease Entity

Research Articles| October 03 2008 Phlebitis saltans, Symptom or Disease Entity? Subject Area: Further Areas , Oncology , Pathology and Cell Biology A. Bollinger; A. Bollinger Departments of Internal Medicine and of Pathology, University of Zurich, Zurich Search for other works by this author on: This Site PubMed Google Scholar H.J. Leu H.J. Leu Departments of Internal Medicine and of Pathology, University of Zurich, Zurich Search for other works by this author on: This Site PubMed Google Scholar Experimental Cell Biology (1975) 43 (2-3): 228–229. https://doi.org/10.1159/000162825 Article history Published Online: October 03 2008 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation A. Bollinger, H.J. Leu; Phlebitis saltans, Symptom or Disease Entity?. Experimental Cell Biology 31 December 1975; 43 (2-3): 228–229. https://doi.org/10.1159/000162825 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsPathobiology Search Advanced Search Article PDF first page preview Close Modal Keywords: Endangiitis obliterans, Morbus Behçet, Collagen vascular disease, Panphlebitis chronica, Salicylic acid This content is only available via PDF. 1975Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.